Bin Xu
Clinical trials sponsored by Bin Xu, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a Feather-Light penile monitor replace the uncomfortable gold standard? Results expected Aug 2027 (estimated)
- Needles vs. leaks: acupuncture trial aims to dry up Post-Surgery accidents Results expected Aug 2027 (estimated)
-
Could a memory drug fight prostate cancer? small trial aims to find out
Disease control Not yet recruitingThis phase 2 trial tests whether memantine hydrochloride, a drug used for Alzheimer's, can help control advanced prostate cancer that has stopped responding to standard hormone therapy. Fifteen men with metastatic castration-resistant prostate cancer will take memantine alongside…
Phase 2 • Sponsor: Bin Xu • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Can a Feather-Light penile monitor replace the uncomfortable gold standard?
Diagnosis Not yet recruitingThis trial evaluates a new ultra-thin flexible penile monitoring system designed to diagnose erectile dysfunction (ED) by measuring nighttime erections. The current standard device, RigiScan, uses mechanical rings that can be uncomfortable and disrupt sleep, potentially skewing r…
Sponsor: Bin Xu • Aim: Diagnosis
Last updated Aug 15, 2026 00:00 UTC
-
Needles vs. leaks: acupuncture trial aims to dry up Post-Surgery accidents
Symptom relief Not yet recruitingThis study tests whether starting acupuncture before the urinary catheter is removed can help men regain bladder control faster after prostate cancer surgery. 144 men will be randomly assigned to receive either real electroacupuncture or a sham (fake) version. The main goal is to…
Sponsor: Bin Xu • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC